Manufacture of basic pharmaceutical products: highest published revenue
30 Belgian companies in the sector (NACE 2110) publish their revenue in recent accounts; here are the top 20. Ajinomoto Omnichem leads with €468.2m (financial year 2026).
Top 20
Ranked by revenue published in the latest filed accounts (accounts less than 3 years old).
| # | Company | Total assets | Revenue | Equity | FTE | Year |
|---|---|---|---|---|---|---|
| 1 | Ajinomoto Omnichem 9230 Wetteren | €476.3m | €468.2m | €323.9m | 863.4 | 2026 |
| 2 | Baxalta Belgium Manufacturing 7860 Lessines | €713.1m | €374.2m | €560.0m | 1,196.8 | 2026 |
| 3 | Telix Innovations 4040 Herstal | €473.4m | €243.8m | €116.7m | 19.8 | 2025 |
| 4 | JNTL Consumer Health (Belgium) 2000 Antwerp | €156.0m | €217.6m | €133.4m | 23.1 | 2025 |
| 5 | PolyPeptide 1420 Braine-l'Alleud | €331.7m | €156.1m | €103.8m | 485.0 | 2025 |
| 6 | Prothya Biosolutions Belgium 1120 Brussels | €134.4m | €109.1m | −€2.24m | 349.0 | 2026 |
| 7 | Mecs Europe/Africa 1560 Hoeilaart | €72.9m | €44.9m | €44.1m | 23.7 | 2025 |
| 8 | S.A. Laboratoires Pharmaceutiques Trenker 1402 Nivelles | €16.1m | €29.0m | €6.35m | 88.2 | 2025 |
| 9 | Belgian Diagnostic Company 6900 Marche-en-Famenne | €8.49m | €17.7m | €1.86m | 134.4 | 2025 |
| 10 | BePharBel Manufacturing 6180 Courcelles | €27.4m | €17.0m | €10.4m | 100.2 | 2025 |
| 11 | Unisensor 4102 Seraing | €19.2m | €12.5m | €13.7m | 59.1 | 2025 |
| 12 | Minakem High Potent 1435 Mont-Saint-Guibert | €32.5m | €12.2m | −€19.4m | 67.8 | 2025 |
| 13 | Catalent Gosselies 6041 Charleroi | €24.2m | €10.0m | −€131.0m | 146.5 | 2025 |
| 14 | Thymolux 6900 Marche-en-Famenne | €6.46m | €6.41m | €4.87m | 23.9 | 2025 |
| 15 | Betaplus Pharma 1200 Woluwe-Saint-Lambert | €24.9m | €5.41m | €22.3m | 11.3 | 2025 |
| 16 | Prevor 4031 Liège | €3.75m | €3.94m | €1.35m | 19.0 | 2025 |
| 17 | Curium PET Liège 4000 Liège | €1.86m | €2.77m | −€2.70m | 12.2 | 2025 |
| 18 | Sartorius Xpress Biologics 4041 Herstal | €10.9m | €2.41m | −€9.49m | 76.2 | 2025 |
| 19 | Unizima 6040 Charleroi | €7.49m | €1.82m | €5.30m | 8.2 | 2023 |
| 20 | Immo 056 7700 Mouscron | €7.03m | €1.02m | €1.53m | — | 2025 |
These are the revenue figures published in the annual accounts. Small companies (micro and abridged accounts) do not have to publish theirs: they do not appear in this ranking.
← The whole Manufacture of basic pharmaceutical products sector
Frequently asked questions
Which company in Manufacture of basic pharmaceutical products has the highest revenue?
Ajinomoto Omnichem, with €468.2m in revenue (financial year 2026).
How many Manufacture of basic pharmaceutical products companies publish their revenue?
30 out of 389, in accounts less than 3 years old. Small companies (micro and abridged accounts) are not required to publish it.
Analyse companies in Manufacture of basic pharmaceutical products
Filter these companies by size, soundness and trend, follow them and get an alert when their accounts or publications change.
Open the full file →Active companies (legal entities) that have filed at least one set of annual accounts, based on the Crossroads Bank for Enterprises and the National Bank of Belgium. The sector is the main activity in the register; the municipality is that of the registered office. Data updated on 13 Nov 2026.